Combined treatment with dipeptidyl peptidase 4 (DPP4) inhibitor sitagliptin and elemental diets reduced indomethacin-induced intestinal injury in rats via the increase of mucosal glucagon-like peptide-2 concentration.
about
Sitagliptin can inhibit the development of hepatic steatosis in high-fructose diet-fed ob/ob mice.Sitagliptin, a dipeptidyl peptidase-4 inhibitor, suppresses CXCL5 and SDF-1 and does not accelerate intestinal neoplasia formation in ApcMin/+ mice fed a high-fat dietFFA3 Activation Stimulates Duodenal Bicarbonate Secretion and Prevents NSAID-Induced Enteropathy via the GLP-2 Pathway in Rats.Effect of egualen sodium hydrate on small-intestinal mucosal damage induced by low-dose aspirin: a prospective randomized clinical trial.Dipeptidyl peptidase-4 inhibitors have adverse effects for the proliferation of human T cells
P2860
Combined treatment with dipeptidyl peptidase 4 (DPP4) inhibitor sitagliptin and elemental diets reduced indomethacin-induced intestinal injury in rats via the increase of mucosal glucagon-like peptide-2 concentration.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Combined treatment with dipept ...... -like peptide-2 concentration.
@en
Combined treatment with dipeptidyl peptidase 4
@nl
type
label
Combined treatment with dipept ...... -like peptide-2 concentration.
@en
Combined treatment with dipeptidyl peptidase 4
@nl
prefLabel
Combined treatment with dipept ...... -like peptide-2 concentration.
@en
Combined treatment with dipeptidyl peptidase 4
@nl
P2093
P2860
P356
P1476
Combined treatment with dipept ...... -like peptide-2 concentration.
@en
P2093
Daisuke Masuda
Eiji Umegaki
Jonathan D Kaunitz
Kaori Fujiwara
Kazuhide Higuchi
Kazuki Kakimoto
Ken Narabayashi
Kumi Ishida
Munetaka Iguchi
Naoki Yorifuji
P2860
P304
P356
10.3164/JCBN.14-111
P577
2015-01-28T00:00:00Z